Arrowhead Pharmaceuticals, Inc. (ARWR): Price and Financial Metrics


Arrowhead Pharmaceuticals, Inc. (ARWR)

Today's Latest Price: $39.93 USD

0.62 (-1.53%)

Updated Feb 19 6:55pm

Add ARWR to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 339 in Biotech

See all "A" rated Strong Buy stocks

ARWR Stock Summary

  • The ratio of debt to operating expenses for Arrowhead Pharmaceuticals Inc is higher than it is for about merely 0.37% of US stocks.
  • With a year-over-year growth in debt of -100%, Arrowhead Pharmaceuticals Inc's debt growth rate surpasses merely 0% of about US stocks.
  • As for revenue growth, note that ARWR's revenue has grown 945.67% over the past 12 months; that beats the revenue growth of 99.17% of US companies in our set.
  • Stocks that are quantitatively similar to ARWR, based on their financial statements, market capitalization, and price volatility, are CRBP, MRUS, AFMD, VYGR, and MDWD.
  • Visit ARWR's SEC page to see the company's official filings. To visit the company's web site, go to arrowheadpharma.com.
ARWR Daily Price Range
ARWR 52-Week Price Range

ARWR Stock Price Chart More Charts


ARWR Price/Volume Stats

Current price $39.93 52-week high $73.72
Prev. close $40.55 52-week low $17.27
Day low $39.89 Volume 842,800
Day high $41.88 Avg. volume 1,687,052
50-day MA $54.69 Dividend yield N/A
200-day MA $38.06 Market Cap 4.06B

Arrowhead Pharmaceuticals, Inc. (ARWR) Company Bio


Arrowhead Pharmaceuticals is a biopharmaceutical company developing targeted RNAi therapeutics. The company was founded in 1989 and is based in Pasadena, California.


ARWR Latest News Stream


Event/TimeNews Detail
Loading, please wait...

ARWR Latest Social Stream


Loading social stream, please wait...

View Full ARWR Social Stream

ARWR Price Returns

1-mo -16.10%
3-mo -18.84%
6-mo 29.31%
1-year 120.61%
3-year 1,740.09%
5-year 441.06%
YTD -37.05%
2019 410.71%
2018 237.50%
2017 137.42%
2016 -74.80%
2015 -16.67%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5819 seconds.